
Panorama Pharmaceuticals Private Limited
About Panorama Pharmaceuticals Private Limited
Data last updated:
Panorama Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 09 February 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG2022PTC159543.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vinay Kumar Annavarapu (Managing Director) and Annavarapu Panakeswari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹15.24 Lakh, a decline of 41% compared to the previous year. For the same year it recorded a net profit of ₹77,599 (net margin 5.1%) and EBITDA of ₹1.17 Lakh (EBITDA margin 7.7%).
Company details
Contact details
Panorama Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressFlat – 202 Sai Balaji Residency, Ksr Enclave, Hyderabad, Telangana, India – 500050
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Panorama Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Panorama Pharmaceuticals Private Limited, buy the company report.
Financials of Panorama Pharmaceuticals Private Limited
FY 2025 filings availablePanorama Pharmaceuticals Private Limited reported revenue of ₹15.24 Lakh (down 41% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 41% in the latest year. EBITDA rose 72% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹1.17 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹77,599 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 7.7% | ||
| Net Profit Margin | 5.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Panorama Pharmaceuticals Private Limited, buy the company report.
Board of directors of Panorama Pharmaceuticals Private Limited
Panorama Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Annavarapu Panakeswari | Director | 09 Feb 2022 | 4 Years 9 Months | Current |
| Vinay Kumar Annavarapu | Managing Director | 09 Feb 2022 | 4 Years 9 Months | Current |
Peer comparison
Panorama Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mehnoor Pharmaceuticals Private Limited | ₹15.29 Lakh (FY 2018) | Bahraich, Uttar Pradesh, India | ||||
| Cato Pharmaceuticals Private Limited | ₹15.29 Lakh (FY 2018) | Kakinada, Andhra Pradesh, India | ||||
| Attentiva Pharmaceuticals Private Limited | ₹15.25 Lakh (FY 2025) | -30.0% | Ranchi, Jharkhand, India | |||
| Panorama Pharmaceuticals Private Limitedthis company | ₹15.24 Lakh (FY 2024) | ₹77,599 | 5.1% | -41.0% | Hyderabad, Telangana, India | |
| Ujiri Pharmaceuticals Private Limited | ₹15.21 Lakh (FY 2025) | -17.0% | Faridabad, Haryana, India | |||
| Bluefinch Pharmaceuticals Private Limited | ₹15.09 Lakh (FY 2025) | -3.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Panorama Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Panorama Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Panorama Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Panorama Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Panorama Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Annavarapu Panakeswari was appointed as Director on 09 Feb 2022.
Frequently asked questions
Panorama Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in specialty, within the trading industry. It was incorporated on 09 February 2022 (4+ years old) and is registered under CIN U51909TG2022PTC159543.
Panorama Pharmaceuticals has 2 current directors:
- Vinay Kumar Annavarapu - Managing Director
- Annavarapu Panakeswari - Director
The latest financial statements of Panorama Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Panorama Pharmaceuticals is U51909TG2022PTC159543. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Panorama Pharmaceuticals was incorporated on 09 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Panorama Pharmaceuticals by revenue are Mehnoor Pharmaceuticals Private Limited, Cato Pharmaceuticals Private Limited, Attentiva Pharmaceuticals Private Limited, Ujiri Pharmaceuticals Private Limited, Bluefinch Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Annavarapu Panakeswari was appointed as Director on 09 Feb 2022. Vinay Kumar Annavarapu was appointed as Managing Director on 09 Feb 2022.
The registered office of Panorama Pharmaceuticals is at Flat – 202 Sai Balaji Residency, Ksr Enclave, Hyderabad, Telangana, India – 500050.
Panorama Pharmaceuticals operates in the trading industry, in the specialty segment.
Panorama Pharmaceuticals can be reached at its registered office: Flat – 202 Sai Balaji Residency, Ksr Enclave, Hyderabad, Telangana, India – 500050.
Panorama Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.

